Application Due Date: March 31, 2021
The National Institute of General Medical Sciences (NIGMS) announces the availability of funds to supplement active Institutional Development Award (IDeA, P20, P30, and U54) and Native American Research Centers for Health (NARCH) (S06) awards for surveillance studies of SARS-CoV-2 viral strains.
Topics: Diagnostics, Antibody Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Viral Detection, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors